Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with ...

Switching to extended half-life therapies for hemophilia enhances treatment adherence and reduces infusion frequency, despite ...

Driven by expensive drugs, hospital stays and growing behavioral health needs, healthcare spending is expected to keep rising ...

An expert discusses how adding an anti-CD38 antibody to a triplet backbone improved minimal residual disease (MRD) negativity ...

H. pylori infection significantly contributes to stomach cancer risk, but effective screening and treatment can prevent ...

A panelist discusses how the FDA approval and NCCN endorsement of retifanlimab plus carboplatin/paclitaxel represents a ...

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...

An expert discusses how patients with vitiligo are often initially misdiagnosed by primary care providers as having fungal ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

The high cost of pharmaceutical products coupled with a lack of federally funded HIV programs create barriers for preexposure ...